We are live on ! Find out more
SHC icon

Sotera Health

16.27 USD
-0.17
1.03%
At close Updated Nov 10, 4:00 PM EST
Pre-market
After hours
16.27
0.00
0%
1 day
-1.03%
5 days
-2.69%
1 month
-10.36%
3 months
-14.23%
6 months
5.44%
Year to date
-8.03%
1 year
3.37%
5 years
-32.55%
10 years
-35.18%
 

About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Employees: 3,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 37.5%
Neutral 62.5%
Negative 0%
Neutral
Seeking Alpha
7 days ago
Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript
Positive
MarketBeat
7 days ago
What Sotera Health (SHC) Said on Its Q3 Earnings Call
Sotera Health NASDAQ: SHC reported third-quarter 2026 revenue growth and higher adjusted EBITDA, while reaffirming its full-year outlook despite softer demand from medical-device customers in Europe that emerged late in the quarter and continued into the start of the fourth quarter.
What Sotera Health (SHC) Said on Its Q3 Earnings Call
Neutral
Zacks Investment Research
7 days ago
Here's What Key Metrics Tell Us About Sotera Health (SHC) Q3 Earnings
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Sotera Health (SHC) Q3 Earnings
Positive
Zacks Investment Research
7 days ago
Sotera Health Company (SHC) Beats Q3 Earnings and Revenue Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago.
Sotera Health Company (SHC) Beats Q3 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
7 days ago
Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
Q3 2026 net revenues increased 4.4% on both an as-reported and constant currency basis (1) , compared to Q3 2025 Q3 2026 net income of $58 million or $0.20 per diluted share Q3 2026 Adjusted EBITDA ( 1 ) increased 3.9%, or 4.0% on a constant currency basis Q3 2026 Adjusted EPS (1) of $0.29, an increase of 12% per diluted share Reaffirming full-year 2026 net revenues growth outlook of 5.25% - 6.75% and Adjusted EBITDA growth outlook of 5.75% - 7.25%, both on a constant currency basis CLEVELAND, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and nine-months ended September 30, 2026. “We are pleased with our third-quarter performance, which included solid top- and bottom-line constant currency growth, along with nearly 100 basis points of sequential Adjusted EBITDA margin expansion,” said Alton Shader, Chief Executive Officer.
Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
Neutral
GlobeNewsWire
20 days ago
Sotera Health Announces Third-Quarter 2026 Earnings Release Date
CLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Tuesday, November 3, 2026. Following the release, management will host a conference call at 9:00 a.m.
Sotera Health Announces Third-Quarter 2026 Earnings Release Date
Positive
Seeking Alpha
1 month ago
Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers
Sotera Health Company is rated BUY, leveraging a vertically integrated model and strong MOAT in global medical equipment sterilization. SHC benefits from high customer switching costs, multi-year contracts with major healthcare firms, and robust pricing power in mission critical services. Q2 2026 results exceeded expectations, prompting raised full-year guidance; SHC trades at a discount to peers on forward EV/EBITDA despite superior margins.
Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers
Neutral
Seeking Alpha
2 months ago
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Neutral
MarketBeat
3 months ago
Sotera Health Q2 Earnings Call Highlights
Sotera Health NASDAQ: SHC reported second-quarter 2026 results that included 8% constant-currency revenue growth, higher adjusted EBITDA margins and an increase to its full-year revenue and adjusted EBITDA outlook.
Sotera Health Q2 Earnings Call Highlights
Neutral
Seeking Alpha
3 months ago
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Price charts implemented using Lightweight Charts™